4//SEC Filing
Fairman Jeff 4
Accession 0001209191-22-023695
CIK 0001649094other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 5:24 PM ET
Size
6.2 KB
Accession
0001209191-22-023695
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-04-05$25.59/sh−5,000$127,950→ 326,227 total(indirect: By Trust)
Holdings
- 16,629
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001813800
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 5:24 PM ET
- Size
- 6.2 KB